Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Assemblies Raises $12.2M in Series A Financing

NEW YORK – Molecular Assemblies today announced it has raised $12.2 million in Series A financing.

The iSelect Fund led the round, joined by existing investors Agilent Technologies, Alexandria Venture Investments, Keshif Ventures. San Diego-based Molecular Assemblies said it will use the proceeds to advance its enzymatic DNA synthesis technology.

"Enzymatic DNA synthesis is the optimal way to create a cost-effective, sustainable, and scalable integrated system that stores and reads information in DNA," Mike Kime, managing director, iSelect Fund, said in a statement. "With a proprietary technology position, Molecular Assemblies' novel enzymatic DNA synthesis platform has the potential to fundamentally transform how we create DNA on demand to enable breakthroughs in life sciences, information storage, synthetic biology, and electronics."

Molecular Assemblies has created a two-step enzymatic DNA synthesis process that can deliver long, pure DNA without a template, on demand. It's one of several teams that are working on enzymatic DNA synthesis methods, including Ansa Biotechnologies and DNA Script. An enzymatic process, in theory, would allow longer oligos and would be less likely to damage the DNA than established chemical methods. In 2018, the firm claimed to be able to store and retrieve digital information in DNA using its process.

"Our ability to reliably, affordably, and sustainably produce long, high-quality DNA can accelerate life science research and transform the information storage industry by enabling integrated systems that can write and read DNA data," Molecular Assemblies President and CEO Michael Kamdar said in a statement.

The firm raised $2.3 million in seed funding in 2016 from Agilent, Cavendish Impact Capital Fund, Eleven Two Capital, Keshif Ventures, Genomics Investment Syndicate, Newport Holdings, and Alexandria Venture Investments.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.